ARROWHEAD PHARMACEUTICALS, INC. Contractual Obligation, to be Paid, Year One
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Contractual Obligation, to be Paid, Year One of $223.82 thousand as of 2018-09-30, per its 10-K filed 2018-12-11.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInNextTwelveMonths · last filed 2018-12-11
- 2018-09-30: Contractual Obligation, to be Paid, Year One $223.82K.
- 2017-09-30: Contractual Obligation, to be Paid, Year One $208.51K.
- 2016-09-30: Contractual Obligation, to be Paid, Year One $194.31K.
| Period end | Contractual Obligation, to be Paid, Year One |
|---|---|
| 2018-09-30 | $223.82K 10-K · filed 2018-12-11 |
| 2017-09-30 | $208.51K 10-K · filed 2017-12-12 |
| 2016-09-30 | $194.31K 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |